By blocking NNMT, it elevates intracellular SAM and NAD+ levels, promoting fat cell differentiation arrest and enhancing metabolic rate

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
The injections are usually given intramuscularly, often in the upper arm or thigh
We'll text you back ASAP
Monitoring Progress Effectively: Rather than relying solely on scale weight, which can be misleading due to muscle preservation and fluid fluctuations, comprehensive progress tracking should include body composition analysis (DEXA scan, bioelectrical impedance, or skinfold measurements), circumference measurements (waist, hips, thighs, arms), progress photos taken in consistent lighting and positioning, and subjective measures like energy levels, appetite patterns, and how clothing fits